ST GALLEN, Switzerland -Friday 18 September 2020 [ AETOS Wire ]

    Vifor Pharma to sell 100% of OM Pharma to Optimus Holding Ltd. for a consideration of MCHF 435
    In addition Vifor Pharma obtains an earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity which could increase the total transaction value in excess of MCHF 500
    Closure of the transaction is expected within 30 days
    Divestment strengthens Vifor Pharma’s focus on becoming the global leader in iron deficiency, nephrology and cardio-renal therapies

(BUSINESS WIRE)-- Regulatory News:

Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include:

    A purchase consideration of MCHF 435 for 100% of the share capital
    ... Read more »

NOVI, Mich. -Friday 18 September 2020 [ AETOS Wire ]

~ Company to use funds to pursue additional new acquisitions and organic expansions to provide added value to customers around the globe ~

~ Investors include Oxford Properties, BentallGreenOak, D1 Capital Partners, Cohen & Steers, OPTrust, CenterSquare Investment Management, Morgan Stanley Tactical Value, among others ~

~ Oxford Properties Group President Michael Turner to join Lineage’s Board of Directors ~

~ Company to name new Board Observers, including BentallGreenOak’s John Carrafiell and SOHO China’s Zhang Xin ~

(BUSINESS WIRE)-- Lineage Logistics, LLC (“Lineage” or the “Company”), the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced it has raised $1.6 billion in equity from new and existing strategic partners. Participating investors include Oxford Propertie ... Read more »

Brazilian construction products manufacturer diverts support savings to help fund product development startups aimed at creating patented innovations and growing revenue

LAS VEGAS-Monday 14 September 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Vedacit, a leading manufacturer of construction products based in Brazil, switched to Rimini Street for support of its Oracle JD Edwards and Database software. By switching to Rimini Street Support, Vedacit was able to free up significant IT budget to drive innovation projects and support its corporate initiative to double revenue by 2023. Specifically, Vedacit leveraged its savings to help fund five product development startups through Vedacit Labs, the company’s innovation incubator that a ... Read more »

 − Key Results from Phase 3 ALTA 1L Sub-Analyses Further Support ALUNBRIG’s Strong Intracranial Efficacy and Enhanced Quality of Life in First-Line ALK+ NSCLC

− Positive 10-Month Follow-Up Data from Phase 1/2 Trial Reaffirm Mobocertinib’s Previously Reported Results in Patients with EGFR Exon20 Insertion+ Metastatic NSCLC

CAMBRIDGE, Mass. & OSAKA, Japan-Sunday 20 September 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the company is presenting data from its lung cancer portfolio at the virtual European Society for Medical Oncology (ESMO) conference. Notably, insights from sub-analyses of the Phase 3 ALTA 1L study reinforce both the compelling evidence of intracranial efficacy with ALUNBRIG® (brigatinib) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) ... Read more »